Drug'On Pharma Switzerland

Drug’On Pharma Switzerland was the last company to be set up in the Orofino Pharmaceuticals Group. The Group bought out the ex Knoll and Abbott manufacturing site in Liestal,Switzerland. The chemical manufacturing site produces active pharmaceuticals ingredients (API) and intermediates and take care about Technology Transfer. Currently there have been important joint venture with primarily chemical companies. The site is RHI-Swissmedic, EU-GMP, FDA and Japan PMDA approved. It consists of four different chemical manufacturing buildings and counts on highly specialized employees. It is also possible to create new departments in some of the buildings,and thanks to the new investments we can provide our customers the possibility of developing other products. Our aim is to bring our contract manufacturing experience and working policy to the Active Pharmaceutical Ingredients field,and at the same time,assuring our customers a high quality service, thanks to the know-how and expertise of our skilled team in Liestal. The multi- purpose site can develop APIs in several therapeutic areas:
  • Antiarrhythmics
  • Antihypertensives
  • Gastrointestinals
  • Anti-infectives
  • Anti-obesity
  • Analgesics
  • Opioids
  • Anesthetics
  • Antidepressants
  • Irtermediate products

Contact us

I would like to receive information for:

Department with which you want to get in touch:

Read More.